Trial Information
Changes of T-cell-immune-status During Curative Radiotherapy in Prostate Cancer
Inclusion Criteria:
- Localised prostate cancer (node negative)
- definitive radiotherapy
- informed consent
Exclusion Criteria:
- medication including steroids or immunosuppressants
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Prospective
Outcome Measure:
T-cell-immunity in time-course
Outcome Time Frame:
During and 3-6 months after radiotherapy
Safety Issue:
No
Principal Investigator
Cihan Gani, M.D.
Investigator Role:
Principal Investigator
Investigator Affiliation:
University Hospital Tuebingen
Authority:
Germany: Federal Institute for Drugs and Medical Devices
Study ID:
UKT_RO_01
NCT ID:
NCT01376674
Start Date:
March 2011
Completion Date:
Related Keywords:
- Prostate Cancer
- localised
- prostate cancer
- radiotherapy
- immunology
- Prostatic Neoplasms